FDA Inspection 1041611 — AmerisourceBergen Drug Corporation
The FDA completed an inspection of AmerisourceBergen Drug Corporation on January 16, 2018 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 16, 2018
- Fiscal Year
- 2018
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Denver, CO (United States)